Topical application of antifibrinolytic drugs for on-pump cardiac surgery: a systematic review and meta-analysis. [L'application topique de médicaments anti-fibrinolytiques pour la chirurgie cardiaque avec circulation extra-corporelle : analyse méthodique et méta-analyse.] [English, French abstract] (se deschide o fereastră nouă)

Abrishami A, Chung F, Wong J.

Sursă‎: Can J Anaesth 2009;56(3):202-12.

Index‎: PubMed 19247741

DOI‎: 10.1007/s12630-008-9038-x

https://www.ncbi.nlm.nih.gov/pubmed/19247741 (se deschide o fereastră nouă)

Can topical application of tranexamic acid reduce blood loss in thoracic surgery? A prospective randomised double blind investigation. (se deschide o fereastră nouă)

Dell'Amore A, Caroli G, Nizar A, Cassanelli N, Luciano G, Greco D, Dolci G, Bini A, Stella F.

Sursă‎: Heart Lung Circ 2012;21(11):706-10.

Index‎: PubMed 22842057

DOI‎: 10.1016/j.hlc.2012.06.016

https://www.ncbi.nlm.nih.gov/pubmed/22842057 (se deschide o fereastră nouă)

Can local application of tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial. (se deschide o fereastră nouă)

Fawzy H, Elmistekawy E, Bonneau D, Latter D, Errett L.

Sursă‎: J Cardiothorac Surg 2009;4:25.

Index‎: PubMed 19538741

DOI‎: 10.1186/1749-8090-4-25

https://www.ncbi.nlm.nih.gov/pubmed/19538741 (se deschide o fereastră nouă)

Current status of pharmacologic therapies in patient blood management. (se deschide o fereastră nouă)

Goodnough LT, Shander A.

Sursă‎: Anesth Analg 2013;116(1):15-34.

Index‎: PubMed 23223098

DOI‎: 10.1213/ANE.0b013e318273f4ae

https://www.ncbi.nlm.nih.gov/pubmed/23223098 (se deschide o fereastră nouă)

The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial. (se deschide o fereastră nouă)

Greilich PE, Jessen ME, Satyanarayana N, Whitten CW, Nuttall GA, Beckham JM, Wall MH, Butterworth JF.

Sursă‎: Anesth Analg 2009;109(1):15-24.

Index‎: PubMed 19535691

DOI‎: 10.1213/ane.0b013e3181a40b5d

https://www.ncbi.nlm.nih.gov/pubmed/19535691 (se deschide o fereastră nouă)

Putting the record straight on aprotinin as safe and effective: results from a mixed treatment meta-analysis of trials of aprotinin. (se deschide o fereastră nouă)

Howell N, Senanayake E, Freemantle N, Pagano D.

Sursă‎: J Thorac Cardiovasc Surg 2013;145(1):234-40.

Index‎: PubMed 22889481

DOI‎: 10.1016/j.jtcvs.2012.07.018

https://www.ncbi.nlm.nih.gov/pubmed/22889481 (se deschide o fereastră nouă)

The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery. (se deschide o fereastră nouă)

Karkouti K, Wijeysundera DN, Yau TM, McCluskey SA, Tait G, Beattie WS.

Sursă‎: Anesth Analg 2010;110(1):21-9.

Index‎: PubMed 19910626

DOI‎: 10.1213/ANE.0b013e3181c0ea6d

https://www.ncbi.nlm.nih.gov/pubmed/19910626 (se deschide o fereastră nouă)

Comparative evaluation of the effects of tranexamic acid and low-dose aprotinin on post-valvular heart surgery bleeding and allogenic transfusion. (se deschide o fereastră nouă)

Mansouri M, Attary M, Bagheri K, Massoumi G, Ghavami B.

Sursă‎: Interact Cardiovasc Thorac Surg 2012;15(1):23-7.

Index‎: PubMed 22514257

DOI‎: 10.1093/icvts/ivs114

https://www.ncbi.nlm.nih.gov/pubmed/22514257 (se deschide o fereastră nouă)

A randomized trial of tranexamic acid in combination with cell salvage plus a meta-analysis of randomized trials evaluating tranexamic acid in off-pump coronary artery bypass grafting. (se deschide o fereastră nouă)

Murphy GJ, Mango E, Lucchetti V, Battaglia F, Catapano D, Rogers CA, Angelini GD.

Sursă‎: J Thorac Cardiovasc Surg 2006;132(3):475-80, 480.e1-8.

Index‎: PubMed 16935098

DOI‎: 10.1016/j.jtcvs.2006.01.064

https://www.ncbi.nlm.nih.gov/pubmed/16935098 (se deschide o fereastră nouă)

Tranexamic acid in patients undergoing coronary-artery surgery. (se deschide o fereastră nouă)

Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, Cooper DJ, Marasco S, McNeil J, Bussières JS, McGuinness S, Byrne K, Chan MT, Landoni G, Wallace S, ATACAS Investigators of the ANZCA Clinical Trials Network

Sursă‎: N Engl J Med 2017;376(2):136-48.

Index‎: PubMed 27774838

DOI‎: 10.1056/NEJMoa1606424

http://www.ncbi.nlm.nih.gov/pubmed/27774838 (se deschide o fereastră nouă)

Aprotinin for patients exposed to clopidogrel before off-pump coronary bypass. (se deschide o fereastră nouă)

Nurözler F, Kutlu T, Küçük G.

Sursă‎: Asian Cardiovasc Thorac Ann 2008;16(6):483-7.

Index‎: PubMed 18984759

DOI‎: 10.1177/021849230801600611

https://www.ncbi.nlm.nih.gov/pubmed/18984759 (se deschide o fereastră nouă)

Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial. (se deschide o fereastră nouă)

Shi J, Ji H, Ren F, Wang G, Xu M, Xue Y, Chen M, Qi J, Li L.

Sursă‎: JAMA Surg 2013;148(6):538-47.

Index‎: PubMed 23426385

DOI‎: 10.1001/jamasurg.2013.1560

https://www.ncbi.nlm.nih.gov/pubmed/23426385 (se deschide o fereastră nouă)

Effect of high- vs low-dose tranexamic acid infusion on need for red blood cell transfusion and adverse events in patients undergoing cardiac surgery: The OPTIMAL randomized clinical trial. (se deschide o fereastră nouă)

Shi J, Zhou C, Pan W, Sun H, Liu S, Feng W, Wang W, Cheng Z, Wang Y, Zheng Z

Sursă‎: JAMA. 2022;328(4):336-47.

Index‎: PubMed 35881121

DOI‎:  10.1001/jama.2022.10725

https://pubmed.ncbi.nlm.nih.gov/35881121/ (se deschide o fereastră nouă)

Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study. (se deschide o fereastră nouă)

Wang G, Xie G, Jiang T, Wang Y, Wang W, Ji H, Liu M, Chen L, Li L.

Sursă‎: Anesth Analg 2012;115(2):239-43.

Index‎: PubMed 21737704

DOI‎: 10.1213/ANE.0b013e3182264a11

https://www.ncbi.nlm.nih.gov/pubmed/21737704 (se deschide o fereastră nouă)

Effects of aprotinin on short-term and long-term outcomes after coronary artery bypass grafting surgery. (se deschide o fereastră nouă)

Wang X, Zheng Z, Ao H, Zhang S, Wang Y, Zhang H, Hu S.

Sursă‎: Ann Thorac Surg 2010;89(5):1489-95.

Index‎: PubMed 20417766

DOI‎: 10.1016/j.athoracsur.2010.02.006

https://www.ncbi.nlm.nih.gov/pubmed/20417766 (se deschide o fereastră nouă)

Low postoperative dose of aprotinin reduces bleeding and is safe in patients receiving clopidogrel before coronary artery bypass surgery. A prospective randomized study. (se deschide o fereastră nouă)

Øvrum E, Tangen G, Tølløfsrud S, Ringdal MA, Øystese R, Istad R.

Sursă‎: Interact Cardiovasc Thorac Surg 2010;10(4):545-8.

Index‎: PubMed 20067988

DOI‎: 10.1510/icvts.2009.226613

https://www.ncbi.nlm.nih.gov/pubmed/20067988 (se deschide o fereastră nouă)

Aortic dissection and hypothermic arrest in a Jehovah's Witness patient: a case for recombinant factor VIIa? (se deschide o fereastră nouă)

Ballen J, Raabe M, Muirhead B.

Sursă‎: Can J Anaesth 2006;53(4):353-6.

Index‎: PubMed 16575032

DOI‎: 10.1007/BF03022498

https://www.ncbi.nlm.nih.gov/pubmed/16575032 (se deschide o fereastră nouă)

Use of recombinant activated factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications. (se deschide o fereastră nouă)

Bhaskar B, Zeigenfuss M, Choudhary J, Fraser JF.

Sursă‎: Transfusion 2013;53(4):798-804.

Index‎: PubMed 22845023

DOI‎: 10.1111/j.1537-2995.2012.03801.x

https://www.ncbi.nlm.nih.gov/pubmed/22845023 (se deschide o fereastră nouă)

Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry. (se deschide o fereastră nouă)

Dunkley S, Phillips L, McCall P, Brereton J, Lindeman R, Jankelowitz G, Cameron P.

Sursă‎: Ann Thorac Surg 2008;85(3):836-44.

Index‎: PubMed 18291152

DOI‎: 10.1016/j.athoracsur.2007.06.076

https://www.ncbi.nlm.nih.gov/pubmed/18291152 (se deschide o fereastră nouă)

Repeat cardiac surgery in a Jehovah's Witness patient with thrombocytopenia. (se deschide o fereastră nouă)

Elmistekawy E, Lapierre H, Bourke M, Dennie C, Labinaz M, Ruel M.

Sursă‎: Can J Cardiol 2011;27(6):869.e7-8.

Index‎: PubMed 21983113

DOI‎: 10.1016/j.cjca.2011.07.632

https://www.ncbi.nlm.nih.gov/pubmed/21983113 (se deschide o fereastră nouă)

Off-label use of recombinant activated factor VII for cardiac surgical bleeding. (se deschide o fereastră nouă)

Flynn BC, Steiner ME, Mazzeffi M

Sursă‎: Anesthesiology. 2023 1;139(2):197-210.

Index‎: PubMed 37155359

DOI‎: 10.1097/ALN.0000000000004569

https://pubmed.ncbi.nlm.nih.gov/37155359/ (se deschide o fereastră nouă)

Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. (se deschide o fereastră nouă)

Gill R, Herbertson M, Vuylsteke A, Olsen PS, von Heymann C, Mythen M, Sellke F, Booth F, Schmidt TA.

Sursă‎: Circulation 2009;120(1):21-7.

Index‎: PubMed 19546387

DOI‎: 10.1161/CIRCULATIONAHA.108.834275

https://www.ncbi.nlm.nih.gov/pubmed/19546387 (se deschide o fereastră nouă)

Intraoperative use of recombinant activated factor VII during complex aortic surgery. (se deschide o fereastră nouă)

Goksedef D, Panagopoulos G, Nassiri N, Levine RL, Hountis PG, Plestis KA.

Sursă‎: J Thorac Cardiovasc Surg 2012;143(5):1198-204.

Index‎: PubMed 22285329

DOI‎: 10.1016/j.jtcvs.2012.01.004

https://www.ncbi.nlm.nih.gov/pubmed/22285329 (se deschide o fereastră nouă)

Off-label use of recombinant human factor VIIa. (se deschide o fereastră nouă)

Goodnough LT, Levy JH.

Sursă‎: Ann Thorac Surg 2014;98(2):393-5.

Index‎: PubMed 25087781

DOI‎: 10.1016/j.athoracsur.2014.06.007

https://www.ncbi.nlm.nih.gov/pubmed/25087781 (se deschide o fereastră nouă)

Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7). (se deschide o fereastră nouă)

Hacquard M, Durand M, Lecompte T, Boini S, Briançon S, Carteaux JP.

Sursă‎: Eur J Cardiothorac Surg 2011;40(6):1320-7.

Index‎: PubMed 21550261

DOI‎: 10.1016/j.ejcts.2011.03.032

https://www.ncbi.nlm.nih.gov/pubmed/21550261 (se deschide o fereastră nouă)

Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery. (se deschide o fereastră nouă)

Karkouti K, Beattie WS, Arellano R, Aye T, Bussieres JS, Callum JL, Cheng D, Heinrich L, Kent B, Lee TW, MacAdams C, Mazer CD, Muirhead B, Rochon AG, Rubens FD, Sawchuk C, Wang S, Waters T, Wong BI, Yau TM.

Sursă‎: Circulation 2008;118(4):331-8.

Index‎: PubMed 18606914

DOI‎: 10.1161/CIRCULATIONAHA.108.764308

https://www.ncbi.nlm.nih.gov/pubmed/18606914 (se deschide o fereastră nouă)

Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery. (se deschide o fereastră nouă)

Končar IB, Davidović LB, Savić N, Sinđelić RB, Ilić N, Dragas M, Markovic M, Kostic D.

Sursă‎: J Vasc Surg 2011;53(4):1032-7.

Index‎: PubMed 21215579

DOI‎: 10.1016/j.jvs.2010.07.075

https://www.ncbi.nlm.nih.gov/pubmed/21215579 (se deschide o fereastră nouă)

Use of activated recombinant factor VII in severe bleeding—evidence for efficacy and safety in trauma, postpartum hemorrhage, cardiac surgery, and gastrointestinal bleeding. (se deschide o fereastră nouă)

Lau P, Ong V, Tan WT, Koh PL, Hartman M.

Sursă‎: Transfus Med Hemother 2012;39(2):139-50.

Index‎: PubMed 22670132

DOI‎: 10.1159/000338034

https://www.ncbi.nlm.nih.gov/pubmed/22670132 (se deschide o fereastră nouă)

Recombinant activated factor VII for postoperative hemorrhage following repair of acute type A aortic dissection. (se deschide o fereastră nouă)

Lehr EJ, Alford TJ, Wang SH.

Sursă‎: Heart Surg Forum 2010;13(5):E275-9.

Index‎: PubMed 20961825

DOI‎: 10.1532/HSF98.20101027

https://www.ncbi.nlm.nih.gov/pubmed/20961825 (se deschide o fereastră nouă)

Recombinant factor VIIa treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, efficacy, and safety outcomes. (se deschide o fereastră nouă)

Masud F, Bostan F, Chi E, Pass SE, Samir H, Stuebing K, Liebl MG.

Sursă‎: J Cardiothorac Vasc Anesth 2009;23(1):28-33.

Index‎: PubMed 18948033

DOI‎: 10.1053/j.jvca.2008.08.003

https://www.ncbi.nlm.nih.gov/pubmed/18948033 (se deschide o fereastră nouă)

Recombinant activated factor VII significantly reduces transfusion requirements in cardiothoracic surgery. (se deschide o fereastră nouă)

Omar HR, Enten G, Karlnoski R, Ching YH, Mangar D, Camporesi EM.

Sursă‎: Drugs R D 2015;15(2):187-94.

Index‎: PubMed 25862216

DOI‎: 10.1007/s40268-015-0093-9

https://www.ncbi.nlm.nih.gov/pubmed/25862216 (se deschide o fereastră nouă)

Hemostatic management of severe thrombocytopenia in a patient undergoing pulmonic valve replacement. (se deschide o fereastră nouă)

Tanaka KA, Li P, McHugh SM, Subramaniam K.

Sursă‎: A A Case Rep 2015;5(1):3-5.

Index‎: PubMed 26125690

DOI‎: 10.1213/XAA.0000000000000166

https://www.ncbi.nlm.nih.gov/pubmed/26125690 (se deschide o fereastră nouă)

Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (Novoseven®). (se deschide o fereastră nouă)

Tanaka KA, Waly AA, Cooper WA, Levy JH.

Sursă‎: Anesthesiology 2003;98(6):1513-5.

Index‎: PubMed 12766668

https://www.ncbi.nlm.nih.gov/pubmed/12766668 (se deschide o fereastră nouă)

Recombinant activated factor VII in cardiac surgery: a systematic review. (se deschide o fereastră nouă)

Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, Darzi A, Athanasiou T.

Sursă‎: Ann Thorac Surg 2007;83(2):707-14.

Index‎: PubMed 17258029

DOI‎: 10.1016/j.athoracsur.2006.10.033

https://www.ncbi.nlm.nih.gov/pubmed/17258029 (se deschide o fereastră nouă)

Reduced use of allogeneic platelets through high-yield perioperative autologous plateletpheresis and reinfusion. (se deschide o fereastră nouă)

Alberts M, Bandarenko N, Gaca J, Lockhart E, Milano C, Alexander S, Linder D, Lombard FW, Welsby IJ.

Sursă‎: Transfusion 2014;54(5):1348-57.

Index‎: PubMed 24898456

DOI‎: 10.1111/trf.12463

https://www.ncbi.nlm.nih.gov/pubmed/24898456 (se deschide o fereastră nouă)

Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery. (se deschide o fereastră nouă)

Arnékian V, Camous J, Fattal S, Rézaiguia-Delclaux S, Nottin R, Stéphan F.

Sursă‎: Interact Cardiovasc Thorac Surg 2012;15(3):382-9.

Index‎: PubMed 22623627

DOI‎: 10.1093/icvts/ivs224

https://www.ncbi.nlm.nih.gov/pubmed/22623627 (se deschide o fereastră nouă)

Reducing blood transfusion in aortic surgery: a novel approach. (se deschide o fereastră nouă)

Birla R, Nawaytou O, Shaw M, Jackson A, Mills K, Kuduvalli M, Field M, Agarwal S

Sursă‎: Ann Thorac Surg 2019;108(5):1369-75.

Index‎: PubMed 31255616

DOI‎: 10.1016/j.athoracsur.2019.04.127

https://www.ncbi.nlm.nih.gov/pubmed/31255616 (se deschide o fereastră nouă)

Prophylactic use of factor IX concentrate in a Jehovah's Witness patient. (se deschide o fereastră nouă)

Bolliger D, Sreeram G, Duncan A, Molinaro RJ, Szlam F, Chen EP, Tanaka KA.

Sursă‎: Ann Thorac Surg 2009;88(5):1666-8.

Index‎: PubMed 19853132

DOI‎: 10.1016/j.athoracsur.2009.03.095

https://www.ncbi.nlm.nih.gov/pubmed/19853132 (se deschide o fereastră nouă)

Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery. (se deschide o fereastră nouă)

Cappabianca G, Mariscalco G, Biancari F, Maselli D, Papesso F, Cottini M, Crosta S, Banescu S, Ahmed AB, Beghi C.

Sursă‎: Crit Care 2016;20:5.

Index‎: PubMed 26738468

DOI‎: 10.1186/s13054-015-1172-6

https://www.ncbi.nlm.nih.gov/pubmed/26738468 (se deschide o fereastră nouă)

Bloodless orthotopic heart transplantation in a Jehovah's Witness. (se deschide o fereastră nouă)

Dallas T, Welsby I, Bottiger B, Milano C, Daneshmand M, Guinn N.

Sursă‎: A A Case Rep 2015;4(10):140-2.

Index‎: PubMed 25974419

DOI‎: 10.1213/XAA.0000000000000067

https://www.ncbi.nlm.nih.gov/pubmed/25974419 (se deschide o fereastră nouă)

State of the art - how I manage coagulopathy in cardiac surgery patients. (se deschide o fereastră nouă)

Davidson S.

Sursă‎: Br J Haematol 2014;164(6):779-89.

Index‎: PubMed 24450971

DOI‎: 10.1111/bjh.12746

https://www.ncbi.nlm.nih.gov/pubmed/24450971 (se deschide o fereastră nouă)

First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. (se deschide o fereastră nouă)

Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J.

Sursă‎: Anesthesiology 2011;115(6):1179-91.

Index‎: PubMed 21970887

DOI‎: 10.1097/ALN.0b013e31823497dd

https://www.ncbi.nlm.nih.gov/pubmed/21970887 (se deschide o fereastră nouă)

Comparison of 4-factor prothrombin complex concentrate with frozen plasma for management of hemorrhage during and after cardiac surgery: a randomized pilot trial. (se deschide o fereastră nouă)

Karkouti K, Bartoszko J, Grewal D, Bingley C, Armali C, Carroll J, Hucke HP, Kron A, McCluskey SA, Rao V, Callum J

Sursă‎: JAMA Netw Open 2021;4(4):e213936.

Index‎: PubMed 33792729

DOI‎: 10.1001/jamanetworkopen.2021.3936

https://www.ncbi.nlm.nih.gov/pubmed/33792729 (se deschide o fereastră nouă)

Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. (se deschide o fereastră nouă)

Karlsson M, Ternström L, Hyllner M, Baghaei F, Flinck A, Skrtic S, Jeppsson A.

Sursă‎: Thromb Haemost 2009;102(1):137-44.

Index‎: PubMed 19572078

DOI‎: 10.1160/TH08-09-0587

https://www.ncbi.nlm.nih.gov/pubmed/19572078 (se deschide o fereastră nouă)

Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial. (se deschide o fereastră nouă)

Rahe-Meyer N, Hanke A, Schmidt DS, Hagl C, Pichlmaier M.

Sursă‎: J Thorac Cardiovasc Surg 2013;145(3 Suppl):S178-85.

Index‎: PubMed 23410777

DOI‎: 10.1016/j.jtcvs.2012.12.083

https://www.ncbi.nlm.nih.gov/pubmed/23410777 (se deschide o fereastră nouă)

Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. (se deschide o fereastră nouă)

Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, Sørensen B, Hagl C, Pichlmaier M.

Sursă‎: Anesthesiology 2013;118(1):40-50.

Index‎: PubMed 23249928

DOI‎: 10.1097/ALN.0b013e3182715d4d

https://www.ncbi.nlm.nih.gov/pubmed/23249928 (se deschide o fereastră nouă)

Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. (se deschide o fereastră nouă)

Ranucci M, Baryshnikova E, Crapelli GB, Rahe-Meyer N, Menicanti L, Frigiola A; Surgical Clinical Outcome REsearch (SCORE) Group.

Sursă‎: J Am Heart Assoc 2015;4(6):e002066.

Index‎: PubMed 26037084

DOI‎: 10.1161/JAHA.115.002066

https://www.ncbi.nlm.nih.gov/pubmed/26037084 (se deschide o fereastră nouă)

Fibrinogen supplementation after cardiac surgery: insights from the zero-plasma trial (ZEPLAST). (se deschide o fereastră nouă)

Ranucci M, Baryshnikova E.

Sursă‎: Br J Anaesth 2016;116(5):618-23.

Index‎: PubMed 26893405

DOI‎: 10.1093/bja/aev539

https://www.ncbi.nlm.nih.gov/pubmed/26893405 (se deschide o fereastră nouă)

Bleeding in a Jehovah's Witness patient undergoing a redo aortic valve replacement controlled with cryoprecipitate and a prothrombin complex concentrate. (se deschide o fereastră nouă)

Robblee JA, Wilkes PR, Dickie SJ, Rubens FD, Bormanis J.

Sursă‎: Can J Anaesth 2012;59(3):299-303.

Index‎: PubMed 22161243

DOI‎: 10.1007/s12630-011-9647-7

https://www.ncbi.nlm.nih.gov/pubmed/22161243 (se deschide o fereastră nouă)

Prothrombin complex concentrate in cardiac surgery: a systematic review and meta-analysis. (se deschide o fereastră nouă)

Roman M, Biancari F, Ahmed AB, Agarwal S, Hadjinikolaou L, Al-Sarraf A, Tsang G, Oo AY, Field M, Santini F, Mariscalco G

Sursă‎: Ann Thorac Surg 2019;107(4):1275-83.

Index‎: PubMed 30458156

DOI‎: 10.1016/j.athoracsur.2018.10.013

https://www.ncbi.nlm.nih.gov/pubmed/30458156 (se deschide o fereastră nouă)

Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of two cases using fractionated components and factor VIIa. (se deschide o fereastră nouă)

Sniecinski RM, Chen EP, Levy JH, Szlam F, Tanaka KA.

Sursă‎: Anesth Analg 2007;104(4):763-5.

Index‎: PubMed 17377078

DOI‎: 10.1213/01.ane.0000250913.45299.f3

https://www.ncbi.nlm.nih.gov/pubmed/17377078 (se deschide o fereastră nouă)

Haemostatic therapy in coronary artery bypass graft patients with decreased platelet function: comparison of fibrinogen concentrate with allogeneic blood products. (se deschide o fereastră nouă)

Solomon C, Schöchl H, Hanke A, Calatzis A, Hagl C, Tanaka K, Rahe-Meyer N.

Sursă‎: Scand J Clin Lab Invest 2012;72(2):121-8.

Index‎: PubMed 22233480

DOI‎: 10.3109/00365513.2011.643818

https://www.ncbi.nlm.nih.gov/pubmed/22233480 (se deschide o fereastră nouă)

Effects of desmopressin on platelet function under conditions of hypothermia and acidosis: an in vitro study using multiple electrode aggregometry. (se deschide o fereastră nouă)

Hanke AA, Dellweg C, Kienbaum P, Weber CF, Görlinger K, Rahe-Meyer N.

Sursă‎: Anaesthesia 2010;65(7):688-91.

Index‎: PubMed 20477783

DOI‎: 10.1111/j.1365-2044.2010.06367.x

https://www.ncbi.nlm.nih.gov/pubmed/20477783 (se deschide o fereastră nouă)

Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy. (se deschide o fereastră nouă)

Ranucci M, Nano G, Pazzaglia A, Bianchi P, Casana R, Tealdi DG.

Sursă‎: J Cardiothorac Vasc Anesth 2007;21(6):851-4.

Index‎: PubMed 18068065

DOI‎: 10.1053/j.jvca.2007.05.009

https://www.ncbi.nlm.nih.gov/pubmed/18068065 (se deschide o fereastră nouă)

Desmopressin for reducing postoperative blood loss and transfusion requirements following cardiac surgery in adults. (se deschide o fereastră nouă)

Wademan BH, Galvin SD.

Sursă‎: Interact Cardiovasc Thorac Surg 2014;18(3):360-70.

Index‎: PubMed 24263581

DOI‎: 10.1093/icvts/ivt491

https://www.ncbi.nlm.nih.gov/pubmed/24263581 (se deschide o fereastră nouă)

A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery. (se deschide o fereastră nouă)

Weber CF, Dietrich W, Spannagl M, Hofstetter C, Jámbor C.

Sursă‎: Anesth Analg 2010;110(3):702-7.

Index‎: PubMed 20042444

DOI‎: 10.1213/ANE.0b013e3181c92a5c

https://www.ncbi.nlm.nih.gov/pubmed/20042444 (se deschide o fereastră nouă)

A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (se deschide o fereastră nouă)

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH.

Sursă‎: Ann Surg 2010;251(2):217-28.

Index‎: PubMed 20010084

DOI‎: 10.1097/SLA.0b013e3181c3bcca

https://www.ncbi.nlm.nih.gov/pubmed/20010084 (se deschide o fereastră nouă)

A review of topical hemostatic agents for use in cardiac surgery. (se deschide o fereastră nouă)

Barnard J, Millner R.

Sursă‎: Ann Thorac Surg 2009;88(4):1377-83.

Index‎: PubMed 19766855

DOI‎: 10.1016/j.athoracsur.2009.02.092

https://www.ncbi.nlm.nih.gov/pubmed/19766855 (se deschide o fereastră nouă)

Armentarium of topical hemostatic products in cardiovascular surgery: an update. (se deschide o fereastră nouă)

Forcillo J, Perrault LP.

Sursă‎: Transfus Apher Sci 2014;50(1):26-31.

Index‎: PubMed 24412443

DOI‎: 10.1016/j.transci.2013.12.009

https://www.ncbi.nlm.nih.gov/pubmed/24412443 (se deschide o fereastră nouă)

A novel reverse thermosensitive polymer to achieve temporary atraumatic vessel occlusion in infra-popliteal bypasses. (se deschide o fereastră nouă)

Mani K, Campbell A, Fitzpatrick J, Modarai B, Carrell T, Rashid H, Zayed H.

Sursă‎: Eur J Vasc Endovasc Surg 2013;45(1):51-6.

Index‎: PubMed 23134676

DOI‎: 10.1016/j.ejvs.2012.10.008

https://www.ncbi.nlm.nih.gov/pubmed/23134676 (se deschide o fereastră nouă)

Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011. (se deschide o fereastră nouă)

Menkis AH, Martin J, Cheng DC, Fitzgerald DC, Freedman JJ, Gao C, Koster A, Mackenzie GS, Murphy GJ, Spiess B, Ad N.

Sursă‎: Innovations (Phila) 2012;7(4):229-41.

Index‎: PubMed 23123988

DOI‎: 10.1097/IMI.0b013e3182747699

https://www.ncbi.nlm.nih.gov/pubmed/23123988 (se deschide o fereastră nouă)

Control of troublesome bleeding during repair of acute type A dissection with use of modified rapid deployment hemostat (MRDH). (se deschide o fereastră nouă)

Salerno TA, Gaughan C, Suarez M, Panos AL.

Sursă‎: J Card Surg 2009;24(6):722-4.

Index‎: PubMed 20078720

DOI‎: 10.1111/j.1540-8191.2009.00915.x

https://www.ncbi.nlm.nih.gov/pubmed/20078720 (se deschide o fereastră nouă)

Topical haemostatic agents. (se deschide o fereastră nouă)

Seyednejad H, Imani M, Jamieson T, Seifalian AM.

Sursă‎: Br J Surg 2008;95(10):1197-225.

Index‎: PubMed 18763249

DOI‎: 10.1002/bjs.6357

https://www.ncbi.nlm.nih.gov/pubmed/18763249 (se deschide o fereastră nouă)

An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. (se deschide o fereastră nouă)

Anderson L, Quasim I, Soutar R, Steven M, Macfie A, Korte W.

Sursă‎: Transfus Med 2006;16(1):31-9.

Index‎: PubMed 16480437

DOI‎: 10.1111/j.1365-3148.2006.00645.x

https://www.ncbi.nlm.nih.gov/pubmed/16480437 (se deschide o fereastră nouă)

First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. (se deschide o fereastră nouă)

Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J.

Sursă‎: Anesthesiology 2011;115(6):1179-91.

Index‎: PubMed 21970887

DOI‎: 10.1097/ALN.0b013e31823497dd

https://www.ncbi.nlm.nih.gov/pubmed/21970887 (se deschide o fereastră nouă)

Management of hemorrhage in cardiothoracic surgery. (se deschide o fereastră nouă)

Görlinger K, Shore-Lesserson L, Dirkmann D, Hanke AA, Rahe-Meyer N, Tanaka KA.

Sursă‎: J Cardiothorac Vasc Anesth 2013;27(4 Suppl):S20-34.

Index‎: PubMed 23910533

DOI‎: 10.1053/j.jvca.2013.05.014

https://www.ncbi.nlm.nih.gov/pubmed/23910533 (se deschide o fereastră nouă)

Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. (se deschide o fereastră nouă)

Weber CF, Görlinger K, Meininger D, Herrmann E, Bingold T, Moritz A, Cohn LH, Zacharowski K.

Sursă‎: Anesthesiology 2012;117(3):531-47.

Index‎: PubMed 22914710

DOI‎: 10.1097/ALN.0b013e318264c644

https://www.ncbi.nlm.nih.gov/pubmed/22914710 (se deschide o fereastră nouă)